Newly marketed hypertension medications include Meyaxartan, Merck Bisoprolol amlodipine tablets and Sacubitril valsartan.
Approved in January 2021 and put into clinical use in May, Meaxartan is a sartan-type antihypertensive drug developed by Takeda of Japan, mainly used for the treatment of essential hypertension, which is effective in improving vascular degeneration, atherosclerosis, lowering blood norepinephrine levels and improving insulin sensitivity.
Merck Bisoprolol Amlodipine Tablets, officially approved for marketing in May 2021, is a single-tablet combination of bisoprolol fumarate and amlodipine benzenesulfonate, which enhances adherence management of hypertensive patients.
Sacubitril valsartan, which was launched in June 2021, can increase glomerular filtration rate, promote vasodilation and inhibit renin release, etc., and is currently widely used in clinical applications.
Regardless of the type of antihypertensive drugs should follow the medical advice to choose the appropriate antihypertensive drugs regular medication and blood pressure monitoring.